Evidence map›Paper›PMID 18371185›Full record

ArticleBrain pathology (Zurich, Switzerland)2008

Myonuclear degeneration in LMNA null mice.

Michel Mittelbronn, Teresa Sullivan, Colin L Stewart, Antje Bornemann

Open access · greenAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Michel MittelbronnInstitute of Neuropathology, University Hospital of Zürich, Switzerland.
Teresa Sullivan
Colin L Stewart
Antje Bornemann
Brain (Germany) · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lamins A/C, the major constituent of the nuclear lamina, confer mechanical stability to nuclei. We examined the myonuclei of LMNA null mice at the myotendinous junctions (MTJ), the site of longitudinal force transmission from contractile proteins to extracellular proteins. The right soleus and rectus femoris muscles of five null mutants aged 5-7 weeks and two wild-type animals aged 5 weeks and 6 months were examined by electron microscopy. The myofibers merging into the tendons were assessed for nuclear disintegration and cytoplasmic degeneration. The myofibers of the wild-type rectus femoris and soleus muscles revealed 19-27 nuclei/50 myofibers and 5-8/20, respectively, with no signs of degeneration. The rectus femoris muscle fibers of the null mice contained 75-117 myonuclei/50 myofibers, the soleus muscle, 13-36 nuclei/20 myofibers. Eleven to twenty-one per 50 myonuclei of the rectus femoris myonuclei showed chromatin clumping, nuclear fragmentation, nuclear inclusions and invaginations, and intranuclear filaments. The values were 12-19/50 for the soleus myonuclei. Moreover, 5-12/50 rectus femoris myofibers and 5-14/20, of the soleus myofibers showed cytoplasmic degeneration. None of these changes was found distal to the MTJ. These results favor the notion that myonuclei lacking a functional lamina are susceptible to mechanical stress in vivo. These alterations may contribute to the development of early joint contractures, a feature of ADEDMD.

Indexed as

AnimalsCell NucleusDisease Models, AnimalLamin Type AMiceMice, KnockoutMicroscopy, Electron, TransmissionMuscle Fibers, SkeletalMuscle, SkeletalMuscular Dystrophy, AnimalMuscular Dystrophy, Emery-DreifussLamin Type A

Identifiers

PMID18371185
PMCPMC8095659
OpenAlexW1981262857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.